Drug safety under the US Best Pharmaceuticals for Children Act

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2003

Schlagwörter:	Simvastatin Atorvastatin Sertraline Safety Issue Oxybutynin

Anmerkung:	© Adis International Ltd 2003

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1392(2003), 1 vom: Juni, Seite 20-20
Übergeordnetes Werk:	volume:1392 ; year:2003 ; number:1 ; month:06 ; pages:20-20

Links:	Volltext

DOI / URN:	10.2165/00128413-200313920-00041

Katalog-ID:	SPR035159391

Internformat


LEADER	01000caa a22002652 4500
001	SPR035159391
003	DE-627
005	20230519184345.0
007	cr uuu---uuuuu
008	201007s2003 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200313920-00041 \|2 doi
035			\|a (DE-627)SPR035159391
035			\|a (SPR)00128413-200313920-00041-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Drug safety under the US Best Pharmaceuticals for Children Act
264		1	\|c 2003
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2003
650		4	\|a Simvastatin \|7 (dpeaa)DE-He213
650		4	\|a Atorvastatin \|7 (dpeaa)DE-He213
650		4	\|a Sertraline \|7 (dpeaa)DE-He213
650		4	\|a Safety Issue \|7 (dpeaa)DE-He213
650		4	\|a Oxybutynin \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1392(2003), 1 vom: Juni, Seite 20-20 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1392 \|g year:2003 \|g number:1 \|g month:06 \|g pages:20-20
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200313920-00041 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1392 \|j 2003 \|e 1 \|c 06 \|h 20-20

Indexfelder

matchkey_str	article:22306056:2003----::rgaeynetesethraetcl
hierarchy_sort_str	2003
publishDate	2003
allfields	10.2165/00128413-200313920-00041 doi (DE-627)SPR035159391 (SPR)00128413-200313920-00041-e DE-627 ger DE-627 rakwb eng Drug safety under the US Best Pharmaceuticals for Children Act 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Simvastatin (dpeaa)DE-He213 Atorvastatin (dpeaa)DE-He213 Sertraline (dpeaa)DE-He213 Safety Issue (dpeaa)DE-He213 Oxybutynin (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1392(2003), 1 vom: Juni, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1392 year:2003 number:1 month:06 pages:20-20 https://dx.doi.org/10.2165/00128413-200313920-00041 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1392 2003 1 06 20-20
spelling	10.2165/00128413-200313920-00041 doi (DE-627)SPR035159391 (SPR)00128413-200313920-00041-e DE-627 ger DE-627 rakwb eng Drug safety under the US Best Pharmaceuticals for Children Act 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Simvastatin (dpeaa)DE-He213 Atorvastatin (dpeaa)DE-He213 Sertraline (dpeaa)DE-He213 Safety Issue (dpeaa)DE-He213 Oxybutynin (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1392(2003), 1 vom: Juni, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1392 year:2003 number:1 month:06 pages:20-20 https://dx.doi.org/10.2165/00128413-200313920-00041 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1392 2003 1 06 20-20
allfields_unstemmed	10.2165/00128413-200313920-00041 doi (DE-627)SPR035159391 (SPR)00128413-200313920-00041-e DE-627 ger DE-627 rakwb eng Drug safety under the US Best Pharmaceuticals for Children Act 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Simvastatin (dpeaa)DE-He213 Atorvastatin (dpeaa)DE-He213 Sertraline (dpeaa)DE-He213 Safety Issue (dpeaa)DE-He213 Oxybutynin (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1392(2003), 1 vom: Juni, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1392 year:2003 number:1 month:06 pages:20-20 https://dx.doi.org/10.2165/00128413-200313920-00041 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1392 2003 1 06 20-20
allfieldsGer	10.2165/00128413-200313920-00041 doi (DE-627)SPR035159391 (SPR)00128413-200313920-00041-e DE-627 ger DE-627 rakwb eng Drug safety under the US Best Pharmaceuticals for Children Act 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Simvastatin (dpeaa)DE-He213 Atorvastatin (dpeaa)DE-He213 Sertraline (dpeaa)DE-He213 Safety Issue (dpeaa)DE-He213 Oxybutynin (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1392(2003), 1 vom: Juni, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1392 year:2003 number:1 month:06 pages:20-20 https://dx.doi.org/10.2165/00128413-200313920-00041 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1392 2003 1 06 20-20
allfieldsSound	10.2165/00128413-200313920-00041 doi (DE-627)SPR035159391 (SPR)00128413-200313920-00041-e DE-627 ger DE-627 rakwb eng Drug safety under the US Best Pharmaceuticals for Children Act 2003 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2003 Simvastatin (dpeaa)DE-He213 Atorvastatin (dpeaa)DE-He213 Sertraline (dpeaa)DE-He213 Safety Issue (dpeaa)DE-He213 Oxybutynin (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1392(2003), 1 vom: Juni, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1392 year:2003 number:1 month:06 pages:20-20 https://dx.doi.org/10.2165/00128413-200313920-00041 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1392 2003 1 06 20-20
language	English
source	Enthalten in Inpharma weekly 1392(2003), 1 vom: Juni, Seite 20-20 volume:1392 year:2003 number:1 month:06 pages:20-20
sourceStr	Enthalten in Inpharma weekly 1392(2003), 1 vom: Juni, Seite 20-20 volume:1392 year:2003 number:1 month:06 pages:20-20
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Simvastatin Atorvastatin Sertraline Safety Issue Oxybutynin
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2003-06-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035159391
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035159391</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519184345.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2003 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200313920-00041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035159391</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200313920-00041-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug safety under the US Best Pharmaceuticals for Children Act</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2003</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2003</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Simvastatin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Atorvastatin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sertraline</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Safety Issue</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oxybutynin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1392(2003), 1 vom: Juni, Seite 20-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1392</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:20-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200313920-00041</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1392</subfield><subfield code="j">2003</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">20-20</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Drug safety under the US Best Pharmaceuticals for Children Act Simvastatin (dpeaa)DE-He213 Atorvastatin (dpeaa)DE-He213 Sertraline (dpeaa)DE-He213 Safety Issue (dpeaa)DE-He213 Oxybutynin (dpeaa)DE-He213
topic	misc Simvastatin misc Atorvastatin misc Sertraline misc Safety Issue misc Oxybutynin
spellingShingle	misc Simvastatin misc Atorvastatin misc Sertraline misc Safety Issue misc Oxybutynin Drug safety under the US Best Pharmaceuticals for Children Act
topic_unstemmed	misc Simvastatin misc Atorvastatin misc Sertraline misc Safety Issue misc Oxybutynin
topic_browse	misc Simvastatin misc Atorvastatin misc Sertraline misc Safety Issue misc Oxybutynin
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Drug safety under the US Best Pharmaceuticals for Children Act
ctrlnum	(DE-627)SPR035159391 (SPR)00128413-200313920-00041-e
title_full	Drug safety under the US Best Pharmaceuticals for Children Act
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2003
contenttype_str_mv	txt
container_start_page	20
container_volume	1392
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200313920-00041
title_sort	drug safety under the us best pharmaceuticals for children act
title_auth	Drug safety under the US Best Pharmaceuticals for Children Act
abstract	© Adis International Ltd 2003
abstractGer	© Adis International Ltd 2003
abstract_unstemmed	© Adis International Ltd 2003
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Drug safety under the US Best Pharmaceuticals for Children Act
url	https://dx.doi.org/10.2165/00128413-200313920-00041
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200313920-00041
up_date	2024-07-03T13:46:09.694Z
_version_	1803565787724644352
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035159391</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519184345.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2003 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200313920-00041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035159391</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200313920-00041-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug safety under the US Best Pharmaceuticals for Children Act</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2003</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2003</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Simvastatin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Atorvastatin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sertraline</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Safety Issue</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oxybutynin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1392(2003), 1 vom: Juni, Seite 20-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1392</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:20-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200313920-00041</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1392</subfield><subfield code="j">2003</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">20-20</subfield></datafield></record></collection>
score	7.3980484

Nicht das Richtige dabei?

Schreiben Sie uns!

Drug safety under the US Best Pharmaceuticals for Children Act

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?